09
Nov
Byetta aka Exenatide: Reports from diabetics of kidney problems & renal failure prompt new warnings from U.S. Food and Drug Administration on diabetes drug.
The U.S. Food and Drug Administration (FDA) has approved new language to be included on the drug label of popular diabetes medication Byetta, also known as exenatide. The new language will include [...]
Posted in Uncategorized by: admin
Comments Off
06
May
Endocrine Today, NJ
The Food and Drug Administration has extended the date of the Prescription Drug User Fee Act from April 30, 2009 to July 30, 2009, stating that additional time is needed to complete the review of saxagliptin for the treatment of Type Two Diabetes.
Topics: prescription, diabetes, Saxagliptin, food and drug administration, type two, News, cells, [...]
Posted in Diabetes News by: admin
Comments Off
06
May
The Diabetes drug Januvia may cause abnormalities in the pancreas, an animal clinical study has found.
Topics: News, Januvia, health, diabetes, diabetes drug, risk, pancreas, Drug, study
Related Articles
Some diabetes drugs linked to eye disorder
FDA: Diabetes drug Onglyza appears safe
Drug Deals Tie Money to How Patients Do
Diabetes Drug Class Linked To Vision Threatening Complication
Posted in Diabetes News by: admin
Comments Off
06
May
BusinessWeek
Drugmakers Bristol-Myers Squibb Co. and AstraZeneca PLC said Thursday federal regulators need more time to review their application for the Diabetes treatment Onglyza. The Food and Drug Administration has extended its deadline for making a decision on …
Topics: food and drug administration, FDA, treatment, fitness, News, cells, Saxagliptin, diabetes, Drug, AstraZeneca
Related Articles
FDA extended time to [...]
Posted in Diabetes News by: admin
Comments Off